Skip to content
Disclosery

EXANE DERIVATIVES: CIEN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CIEN, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,411 CIEN shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,411 shares
    Change vs previous 13F -3,388 shares

    0.09% of the 13F portfolio, value $155,866.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,799 shares
    Change vs previous 13F -3,506 shares

    0.12% of the 13F portfolio, value $412,232.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 10,305 shares
    Change vs previous 13F -264 shares

    0.19% of the 13F portfolio, value $793,212.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 10,569 shares
    Change vs previous 13F +1,280 shares

    0.14% of the 13F portfolio, value $542,743.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,289 shares
    Change vs previous 13F +8,075 shares

    0.12% of the 13F portfolio, value $528,187.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,214 shares
    Change vs previous 13F -7,245 shares

    0.02% of the 13F portfolio, value $66,434.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 8,459 shares
    Change vs previous 13F -127 shares

    0.14% of the 13F portfolio, value $447,082.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 8,586 shares
    Change vs previous 13F not available

    0.11% of the 13F portfolio, value $340,788.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).